NCT03539887: Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
- State
- Completed
- Phase
- Phase 3
- People
- 33 taking part
- Started
- 1 May 2018
- Primary completion
- 15 Jan 2022
- Arms
- Intranasal ketamine
- Results
- Posted on the registry
- 1 May 2018: Trial started
- 29 May 2018: Trial registered
- 15 Jan 2022: Trial completed
- 1 Mar 2023: Trial results posted